Companies: 10,795·Total market cap: $144.5T
Structure Therapeutics Inc.

Structure Therapeutics Inc.

GPCRNASDAQHealthcare● Active
$37.58
$-1.48(-3.79%)
Market Cap$2.2B
P/E Ratio—
52W High$94.9
52W Low$15.8
SEC Filings

Structure Therapeutics Inc. (GPCR) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001888886 · GPCR · NASDAQ · as of Jun 8, 2026

Filing snapshot

248
Total Filings
10-Q
Latest Form
2026-05-07
Most Recent
2023
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001888886 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-26
Fiscal Year End
Feb 26, 2026
Accession No.
0001104659-26-020562
Primary Document
gpcr-20251231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001888886 · Accession 0001104659-26-020562

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-05-07Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2026-05-07
View
8-KCurrent Report
FORM 8-K
2026-05-07
View
424B5424B5
424B5
2026-05-07
View
ARSARS
ARS
2026-04-23
View
DEF 14AProxy Statement
DEF 14A
2026-04-23
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-23
View
8-KCurrent Report
FORM 8-K
2026-04-15
View
8-KCurrent Report
FORM 8-K
2026-03-16
View
S-8Employee Stock Plan Registration
FORM S-8
2026-02-26
View
10-KAnnual Report
10-K
2026-02-26
View
8-KCurrent Report
FORM 8-K
2026-02-26
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-10
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-05
View
Showing 1–15 of 167 filingsForm 4 / 144 hidden· 248 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001888886  |  Exchange: NASDAQ · Healthcare

Structure Therapeutics Inc. (NASDAQ: GPCR) has submitted 248 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2023. As a Healthcare sector company with CIK 0001888886, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Structure Therapeutics Inc.'s most comprehensive regulatory disclosure. The most recent Structure Therapeutics Inc. 10-K was filed on 2026-02-26 for fiscal year ending 2026. Historical GPCR 10-K annual reports are available from 2021 through 2026.

Investors researching Structure Therapeutics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
LQDA SEC Filings →EWTX SEC Filings →CLDX SEC Filings →GLPG SEC Filings →OCUL SEC Filings →MESO SEC Filings →QURE SEC Filings →ABCL SEC Filings →
→ GPCR Financials→ GPCR Earnings→ GPCR Insider Trades

Frequently Asked Questions

GPCR SEC Filings · 8 questions

Structure Therapeutics Inc. (GPCR) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 248 filings and access original documents at no cost. Structure Therapeutics Inc.'s CIK is 0001888886.

GPCR SEC filingsStructure Therapeutics Inc. SEC documentsfind GPCR 10-K